Company / Operating Income per Share
Oncology Institute, Inc. Operating Income per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.79
FY2025
5-year range
-$1.12 / -$0.11
FY2021-FY2025
Trend
+23.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-1.12 to $-0.79 over the past 2 years.
Based on SEC 10-K filings.
-0.79 in FY2025.
Improved from $-1.12 to $-0.79 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 23.6% year-over-year.
- Peak operating income per share was recorded in FY2021.
- Lowest operating income per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.79 | +23.6% |
| FY2024 | -$1.04 | +7.1% |
| FY2023 | -$1.12 | -78.7% |
| FY2022 | -$0.63 | -459.4% |
| FY2021 | -$0.11 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026